Live

Watch CBSN Live

Bernie Sanders on "skyrocketing" price of insulin

Between 2002 and 2013, the price of insulin more than tripled, to more than $700 per patient. A federal lawsuit accuses three insulin manufacturers -- Eli Lilly, Novo Nordisk and Sanofi -- of conspiring to raise their prices. Vermont Sen. Bernie Sanders is calling for a federal investigation, alleging collusion among the companies. The drug makers deny the allegations.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.